1. The incorporation of methyl groups into histones from dimethylnitrosamine and from methionine was studied by injection of the labelled compounds, isolation of rat liver and kidney histones, and analysis of hydrolysates by column chromatography. 2. Labelled methionine gave rise to labelled e-N-methyllysine, di-e-N-methyl-lysine and an amino acid presumed to be w-N-methylarginine. 3. Administration of labelled dimethylnitrosamine gave rise to labelled S-methylcysteine, 1-methylhistidine, 3-methylhistidine and e-N-methyl-lysine derived from the alkylating metabolite of dimethylnitrosamine. In addition, labelled formaldehyde released by metabolism of dimethylnitrosamine leads to the formation of labelled S-adenosylmethionine, and hence to labelling of e-N-methyl-lysine, di-e-N-methyl-lysine and w-N-methylarginine by enzymic methylation. 4. The formation of e-N-methyl-lysine by alkylation of liver histones was confirmed by using doubly labelled dimethylnitrosamine to discriminate between direct chemical alkylation and enzymic methylation via S-adenosylmethionine. These experiments also suggested the possibility that methionine residues in the histones were alkylated to give methylmethionine sulphonium residues. 5. The extent of alkylation of liver histones was maximal at about 5h after dosing and declined between 5 and 24h. The methylated amino acids resulting from direct chemical alkylation were preferentially lost:
1. The incorporation of methyl groups into histones from dimethylnitrosamine and from methionine was studied by injection of the labelled compounds, isolation of rat liver and kidney histones, and analysis of hydrolysates by column chromatography. 2. Labelled methionine gave rise to labelled e-N-methyllysine, di-e-N-methyl-lysine and an amino acid presumed to be w-N-methylarginine. 3 . Administration of labelled dimethylnitrosamine gave rise to labelled S-methylcysteine, 1-methylhistidine, 3-methylhistidine and e-N-methyl-lysine derived from the alkylating metabolite of dimethylnitrosamine. In addition, labelled formaldehyde released by metabolism of dimethylnitrosamine leads to the formation of labelled S-adenosylmethionine, and hence to labelling of e-N-methyl-lysine, di-e-N-methyl-lysine and w-N-methylarginine by enzymic methylation. 4 . The formation of e-N-methyl-lysine by alkylation of liver histones was confirmed by using doubly labelled dimethylnitrosamine to discriminate between direct chemical alkylation and enzymic methylation via S-adenosylmethionine. These experiments also suggested the possibility that methionine residues in the histones were alkylated to give methylmethionine sulphonium residues. 5. The extent of alkylation of liver histones was maximal at about 5h after dosing and declined between 5 and 24h. The methylated amino acids resulting from direct chemical alkylation were preferentially lost:
this is ascribed to necrosis of the more highly alkylated cells. 6. Liver histones were about four times as alkylated as kidney histones; the extent of alkylation of liver histones was similar to that of liver total nuclear proteins. 7. Methyl methanesulphonate (120mg/kg) alkylated liver histones to a greater extent than did dimethylnitrosamine. Diethylnitrosamine also alkylated liver histones. 8. The results are discussed with regard to the possible effects of alkylation on histone function, and the possible role of histone alkylation in carcinogenesis by the three compounds.
Although it has often been suggested that histones regulate genetic activity (Stedman & Stedman, 1950; Allfrey, 1966 Allfrey, , 1970 Bonner et al. 1968; Butler, Johns & Phillips, 1968; Stellwagen & Cole, 1969; Dahmus & Bonner, 1970) , a current view is that the histones function as non-specific gene repressors, and that specificity may be due to other components ofthe epigenetic system (Paul, Gilmour, Thomou, Threlfall & Kohl, 1970) . As gene repressors, they are candidates for a role in a mechanism of carcinogenesis based on a cellular change at the level of differentiation rather than at the genetic level (Pitot & Heidelberger, 1963) .
Histones are subject to a variety of structural modifications at the polypeptide level, including methylation (Murray, 1964; Allfrey, Faulkner & Mirsky, 1964 ; Kim & Paik, 1965) , acetylation (Allfrey et al. 1964) , phosphorylation (Ord & Stocken, 1966; Kleinsmith, Allfrey & Mirsky, 1966) and oxidation-reduction (Hilton & Stocken, 1966) . Of these, methylation is of particular relevance to this investigation. The methylated components so far found in histones are E-N-methyl-lysine (Murray, 1964) , di-e-N-methyl-lysine (Paik & Kim, 1967) , tri-e-N-methyl-lysine (Hempel, Lange & Birkofer, 1968) , 3-methylhistidine (Gershey, Haslett, Vidali & Allfrey, 1969) , w-N-methylarginine (Paik & Kim, 1970) and two di-w-N-methylarginines (Nakajima, Matsuoka & Kakimoto, 1971) . The methyl groups are derived from methionine (Murray, 1964; Allfrey et al. 1964 ) via S-adenosylmethionine (Kim & Paik, 1965) . The effect of 725 C. TURBERVILLE AND V. M. CRADDOCK methylation on the function of histones is at present obscure: Alifrey et al. (1964) suggested that methylation might affect the ability of histones to repress RNA synthesis, but Tidwell, Allfrey & Mirsky (1968) found no correlation between histone methylation and increased RNA synthesis or DNA synthesis in regenerating rat liver. The latter authors suggested that the methylation of histones may be related to chromosomal changes during the period preceding mitosis.
The methylation of histones is of interest in connexion with dimethylnitrosamine because the carcinogen may act by methylating one or more cellular macromolecules (Magee, Craddock & Swann, 1967) . The nucleic acids in livers and kidneys ofrats treated with dimethylnitrosamine are methylated, mainly in the 7-position of guanine residues (Magee & Farber, 1962; Craddock & Magee, 1963) . Magee & Hultin (1962) showed that the incubation of liver slices with dimethylnitrosamine in vitro led to methylation of proteins at the 1-and 3-positions of histidine residues. Methylation of liver proteins also occurs when dimethylnitrosamine is administered to rats; the sites of methylation are histidine residues and a very small proportion of cysteine residues (Craddock, 1965) . Dimethylnitrosamine is oxidized by a microsomal enzyme system (Scheme 1), the products being formaldehyde and an active methylating intermediate which is thought to be the proximate carcinogen (see Magee & Barnes, 1967; Magee & Swann, 1969) . The active intermediate may be a methylcarbonium ion since methyl groups derived from dimethylnitrosamine are transferred intact, without loss of hydrogen atoms, to nucleic acids (Lijinsky, Loo & Ross, 1968) . Most ofthe alkylating intermediate will react immediately with water, to form methanol. Thus a large proportion of the radioactivity from labelled dimethylnitrosamine will be metabolized via formaldehyde; this becomes incorporated into normal metabolites through the C, pool (Magee & Hultin, 1962; Magee & Farber, 1962) and these products must therefore be distinguished from those due to alkylation. The (Rachele, White & Griinewald, 1964 (Bruce & Parkes, 1956) . Female rats of 190-210g body wt. were used. All compounds were administered by intraperitoneal injection in about 1 ml of saline (0.85% NaCl) except diethylnitrosamine, which was injected in 3 ml of saline.
[14C]Methyl methanesulphonate, supplied in solution in diethyl ether, was prepared for administration to the rats by adding saline and evaporating off the ether with a gentle stream of air.
Chemical&. The following ohemicals were obtained from the sources indioated: Aldrich Chemical Co. Inc., Milwaukee, Wis., U.S.A., methyl methanesulphonate; BDH Chemicals Ltd., Poole, Dorset, U.K., S-adenosyl-L-methionine chloride, dimethylnitrosamine (redistilled; b.p. 151'C); Calbiochem, Los Angeles, Calif., U.S.A., e-N-methyl-L-lysine hydrochloride, a-N-acetyl-L-lysine, 3-methyl-L-histidine, 1-methyl-L-histidine hydrate, Cyolo Chemical Corp., Los Angeles, Calif., U.S.A., c-N-methyl-L-lysine, di-e-N-methyl-L-lysine hemihydrate; Ralph N. Emmanuel Ltd., London S.E.1, U.K., S-methyl-Lcysteine, S-methyl-DL-methionine sulphonium chloride; K & K Laboratories Inc., Plainview, N.Y., U.S.A., O-methyl-DL-serine. oc-N-Benzoyltri-e-N-methyl-L-lysine chloroaurate was a gift from Dr N. L. Benoiton (Seely & Benoiton, 1970) . For use as a chromatographic standard for tri-e-N-methyl-lysine, 15mg of this compound was hydrolysed in 2.5ml of 6m-HCl in an evacuated sealed tube at 110°C for 72h. The solution was diluted with water and evaporated to dryness; this was repeated twice to remove excess of HCI. The residue was taken up in water slightly acidified with HIC and extraoted three times with diethyl ether to remove gold salts (Cotton & Wilkinson, 1962) . Di-E-N-methyl-L-lysine monohydrochloride was synthesized from a-N-acetyl-L-lysine by the method of Benoiton (1964) . The yield was only 20%, and the product was amorphous and hygroscopic; however, it behaved homogeneously on paper chromatography (systems 1, 3, 4 and 5, see below).
Radioactive compound8. in an evacuated sealed tube at 108°C for 22 h. After centrifugation to remove black insoluble material, the solution was diluted to 1 M-HCI, and applied to a column of Dowex AG-50W (X8) cation-exchange resin equilibrated with 1M-HCl containing 0.5% thiodiglycol. In earlier experiments, a column measuring 50cm x 1.0cm was used; later, this was replaced by one measuring 100cm x 0.8 cm.
The column was eluted with 900 ml (short column) or 1200ml (long column) of 1 M-HCl containing 0.5% thiodiglycol, followed by 2M-HCI. The flow rate was 15-20ml/ h. The effluent was collected in 1Oml fractions. A sample from each fraction was used for measurement of radioactivity. The presence of amino acids was detected by transferring a 25,ul sample of each fraction to a sheet of paper, drying, and spraying with ninhydrin solution, or Pauly or Sakaguchi reagent (see below).
Paper chromatography. Paper chromatography was carried out overnight by descending development on Whatman no. 1 paper, with the following solvent systems.
(1) Phenol-m-cresol-borate buffer, pH9.3 (25:25:7, by wt.) (Levy & Chung, 1953) ; (2) m-cresolborate buffer, pH9.3 (50:7, w/w) (Levy & Chung, 1953) ; (3) phenol-borate buffer, pH9.3 (50:7, w/w) (Levy & Chung, 1953) ; (4) butan-l-ol-acetic acid-water (12:3:5, by vol.); (5) propan-2-ol-oone. HCl-water (34: 9: 7, by vol.) (Wyatt, 1951) ; (6) ethanol-acetic acid-water (65:1:34, by vol.) (Schlenk & De Palma, 1957) . Appropriate amino acid standards were included on each sheet. The following spray reagents were used to detect amino acids on paper chromatograms or spot-test sheets: (a) ninhydrin, 0.2% in acetone containing 2% pyridine (Smith, 1953) ; (b) sulphanilamide (Pauly) reagent (Block, Durrum & Zweig, 1958) ; (c) Sakaguchi reagent (Acher & Crocker, 1952) . When radioactive compounds were chromatographed, the strip containing the unknown material was cut into sections, which were extracted twice with 5ml of 1M-HCl. The two extracts were combined, evaporated to dryness with a stream of warm air, and their radlioactivities assayed as described below.
Separation of S-adeno8ylmethionine. Rats injected with radioactive dimethylnitrosamine were killed after 1, 2 or 5h and the livers rapidly removed into 30ml of ice-cold 0.4M-HC104. The liver was homogenized in the HC104 at 4°C by using an MSE blade homogenizer and centrifuged at 1200g for 30 min. The supernatant was loaded on to a column (12 cm x 1cm) of Dowex AG-50W (X8) resin equilibrated with 1 M-HCl. The column was eluted at a flow rate of 30 ml/h with an exponential gradient of 1-4M-HCI, starting with 300 ml of 1 M-HCl in the mixing flask; lOml fractions were collected. The E257 of each fraction was measured with a Unicam SP. 500 spectrophotometer. At first the fractions were evaporated to dryness and their radioactivities assayed as below. However, in subsequent double-labelling experiments it was found that the isotope ratio (3H d.p.m./14C d.p.m.) varied across the peak corresponding to adenosylmethionine in such a way that the ratio was at a minimum when the total activity/fraction was at a maximum. This could be explained if the adenosylmethionine peak was contaminated with a broad peak of high 3H/14C ratio. Rechromatography of the pooled adenosylmethionine fractions on the same column did not remove the contamination. Thus in the experiments described here, the method was modified as follows: after reading the extinction of the column fractions, the absorbing fractions corresponding to adenosylmethionine were pooled and evaporated to dryness. The residue was taken up in a little dilute HC1 and chromatographed on Whatman no. 1 paper for 12h in solvent (6). The strip containing the sample was cut into sections which were extracted twice with 1 M-HCl. The extracts were combined and evaporated, and the radioactivity was assayed. It was found that in addition to a radioactive u.v.-absorbing spot corresponding to adenosylmethionine, there was also a faster-moving spot with a very high 3H/14C ratio, which could account for the contamination described. The 3H/14C ratio was constant across the adenosylmethionine spot and this value was therefore used as the isotope ratio of adenosylmethionine.
Measurement-of radioactivity. Radioactivity was measured by liquid-scintillation counting, as described by Craddock & Magee (1966) .
The 3H/14C ratios in the administered dose of doubly labelled compounds were measured as follows. The dose was made up in a scintillation vial. After using nearly all the solution for injections, 1.0 ml of Hyamine solution (Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K.) was added to the vial, followed by 10ml of 2,5-diphenyloxazole (0.6% in toluene). After mixing, O.1ml of the contents was transferred to each of three vials, to which was added lOml of the 2,5-diphenyloxazole solution. Efficiencies and channel overlaps were determined by adding an internal standard of [3H]toluene, followed by a standard of [14C]toluene.
Calculation of proportion of radioactivity derived from the alkylating intermediate. Methyl groups derived from the alkylating intermediate will have a 3H/14C ratio equal to that of the injected dimethylnitrosamine (Rd). Methyl groups derived from C1 intermediates will have a 3H/14C ratio equal to that of S-adenosylmethionine (Ra). If the total 14C d.p.m. in the chromatographic peak is c, and the fraction of these derived from the alkylating intermediate is f, then the total 3H d.p.m., h, in the peak will be given by:
(1) h= RJc (2) where Rp is the 3H/14C ratio of the peak. By combining eqns. (1) and (2) (Craddock & Magee, 1963) . In all the experiments with dimethylnitrosamine a dose of 27-30mg/kg was used;
this is slightly less than the LD50 dose (Magee & Barnes, 1967) . The amounts of radioactivity found in histone preparations of rats injected with [14C]dimethylnitrosamine were too low to permit characterization of the radioactive amino acids by paper chromatography. To obtain a guide to the nature of the modified amino acids, the alkylation of the total nuclear proteins in the livers of rats treated with dimethylnitrosamine of a higher specific radioactivity was investigated by using a protein preparation obtained by Dr S. Villa-Trevino from a phenol-extraction procedure (Lawley, Brookes, Magee, Craddock & Swann, 1968) . The amino acid composition of the nuclear protein preparation is shown in Table 1 . The high lysine content suggested that this preparation contained a considerable proportion of histones and hence might provide a useful guide to the situation in pure histones. Fig. 1 shows the radioactivity profile from ion-exchange chromatography of a hydrolysate of these proteins. Radioactivity is incorporated into several non-methylated as well as into the methyl groups of methylated amino acids. The radioactive amino acids were identified by their retention volumes and by paper chromatography (summarized in Table 2 ).
Peak A (Fig. 1 ) elutes from the column before aspartic acid, and is therefore probably not an amino acid but possibly an acidic or a low-molecularweight non-polar compound. It occurs also in hydrolysates of histones from animals treated with radioactive dimethylnitrosamine or radioactive formate and is therefore probably not a product of alkylation. This substance has not yet been identified. The results are consistent with peak B being serine, peak C alanine, peak E methionine and peak F cystine.
The retention volume of peak D was similar but not identical with those of valine and proline, but Fig. 1 .
Identification
Chromatographic systems Unknown Serine (+ some glutamic acid) 1, 4; two-dimensional (4 followed by 2) coincided with that of S-methylcysteine. Paper chromatography showed that the radioactivity in peak D is due to S-methylcysteine, possibly with some contribution from proline. Craddock (1965) showed that, in rats treated with [14C] Peaks G, H and I elute after lysine and histidine but before arginine. Peak G has a retention volume corresponding to that of e-N-methyl-lysine and peak I corresponds to 3-methylhistidine. Paper chromatography in system (1) confirms these identifications. Peak H has a retention volume similar to those of di-e-N-methyl-lysine, tri-e-Nmethyl-lysine and 1-methylhistidine, which are not resolved by the column chromatography. Vhen peak H was chromatographed in system (3), 80% of the radioactivity migrated as 1-methylhistidine, 12% as dimethyl-lysine and 6% as trimethyl. lysine. Peak J elutes close to arginine and therefore could be a methylated arginine (Paik & Kim, 1970; Nakajima et al. 1971) .
With the help of the identifications made with this more-radioactive material, it was possible to identify by comparison of profiles the radioactive peaks in a hydrolysate of liver histones from rats treated with [14C]dimethylnitrosamine (Fig. 2) . Kidney histones from the same animals gave a qualitatively similar radioactivity profile on column chromatography, but had lower amounts of radioactivity. Thus, in livers and kidneys of dimethylnitrosamine-treated animals, the histones contain methyl-lysine, methylhistidine and methylcysteine residues.
The radioactive labelling of the methyl-lysine residues could be due to their formation by the methylation of histones by the alkylating metabolite of dimethylnitrosamine; or it could be due to the incorporation of [14C]formaldehyde through the Cl system into methionine and hence into normal methyl groups. The fact that methionine in the histone is labelled (Fig. 2) reinforces the latter possibility. To check this, experiments were carried out with radioactive methyl group precursors to label the histones. Fig. 3 shows the radioactivity profile from the ion-exchange chromatography of a hydrolysate of liver histones from rats injected with L-[Me-14C]methionine. This shows that methyl-lysine and dimethyl-lysine are labelled by this precursor. However, more radioactivity is present in dimethyl-lysine than in methyl-lysine, whereas the reverse is true in histones from rats treated with [14C]dimethylnitrosamine (Fig. 2) . This would suggest that some methyl-lysine in histones is formed as a result of alkylation by the active metabolite of dimethylnitrosamine, in addition to the probable formation of methyl groups in methyl-lysine and dimethyl-lysine from formaldehyde.
In addition to methyl-lysine and dimethyl-lysine, the amino acids labelled from [14C]methionine are methionine and the presumed methylarginine (Fig.  3) . Small amounts of radioactivity are present in serine, alanine and proline. The identifications of methyl-lysine, dimethyl-lysine, methionine and serine were checked by paper chromatography in systems (1) and (4). A further confirmation of the identification of methyl-lysine and dimethyl-lysine was obtained by injecting rats with both L-[U-14C]_ lysine (12.5,uCi/rat) and L-[Me_3H]methionine (250,uCi/rat). The peaks of 3H radioactivity corresponded to two peaks of 14C radioactivity. The second peak had a 3H/14C radioactivity (d.p.m.) ratio of 414, whereas the value for the first peak was 204, indicating that the second contained twice as many methyl groups per lysine residue as the first. This would be consistent with their being dimethyl-lysine and methyl-lysine respectively. In this chromatographic run, as with several others, the radioactivity profile of the dimethyl-lysine peak had a shoulder in the position of trimethyl-lysine, which may thus account for a minor proportion of the radioactivity of this peak.
When sodium [14C]formate is used as precursor, a much greater proportion of the radioactivity of liver bistones is recovered as serine and the other non-methylated amino acids, but labelling of the methylated amino acids still occurs (Fig. 4) . At least part of the labelling of these histone constituents after treatment with [14C]dimethylnitrosamine could therefore be explained by the enzymic incorporation of labelled methyl groups derived from formaldehyde. It is necessary to distinguish between these methyl groups and those resulting from methylation of histones by the active metabolite of dimethylnitrosamine.
The two kinds of methyl groups differ in the number of their hydrogen atoms derived from the parent molecule. Lijinsky et al. (1968) Table 3 shows the results of such an experiment. Methyl-lysine and methylcysteine had isotope ratios approaching that of the injected dimethylnitrosamine, and the peak containing dimethyl-lysine and 1-methylhistidine had a lower value. However, the isotope ratios of serine and methionine are both greater than one-third of the dimethylnitrosamine value, which is the expected value if they were labelled via formate. Methionine has an isotope ratio approximately equal to that of dimethylnitrosamine. Since S-adenosylmethionine, formed 732 1971 killed after 1, 2 or 5h and S-adenosylmethionine was separated from a perchloric acid extract of the livers as described in the Methods section. S-Adenosylmethionine was eluted from the ionexchange column after adenine. Fig. 5 illustrates a typical chromatogram in system (6) of material from the pooled fractions corresponding to the adenosylmethionine peak obtained by column chromatography. The doubly labelled adenosylmethionine is separated from bands having a very high 3H/14C ratio. Table 4 summarizes the results of these experiments. The isotope ratio of adenosylmethionine is constant over the period studied. Relative to that of the injected dimethylnitrosamine, it is lower than the ratio in methionine in histones (Table 3) , and very similar to that of serine, although both are higher than the theoretical value for formate of one-third of the dimethylnitrosamine ratio. However, the isotope ratios of the methylated lysines (Table 3) section ). In the case of methyl-lysine, 75% of the labelling is due to alkylation and 25% to enzymic incorporation via adenosylmethionine; in the case of the dimethyl-lysine-l-methylhistidine peak, 41% is due to alkylation. Since the proportion of monomethylated lysine residues is very low, further methylation by the alkylating intermediate would be kinetically disfavoured, and therefore little dimethyl-lysine would be formed from the alkylating intermediate; so that it is reasonable to suggest that the 41% of alkylated product consists of 1-methylhistidine and the remaining 59% of dimethyllysine labelled via adenosylmethionine. This assumption would give a 1-methylhistidine/3-methylhistidine ratio of 1.7, which agrees quite well with the results of Magee & Hultin (1962) who obtained 1-methylhistidine and 3-methylhistidine labelled in a ratio of approx. 1.4:1. On this basis, and assuming the specific radioactivity of alkylated products to be the same as that of dimethylnitrosamine, the levels ofalkylation shown in Table 5 were calculated from two separate experiments.
The time-course of alkylation of histones was investigated by injecting rats with [14C]dimethylnitrosamine and killing 2, 5 or 24h later. These times were chosen because of the known rates of decomposition of this dose of dimethylnitrosamine in the rat: most of the compound has been metabolized by 5h, and none is left by 24h (Heath, 1962) . Fig. 6 shows the radioactivity profile obtained by column chromatography of a hydrolysate of liver histones from the 24h experiment. Methyl-lysine, 3-methylhistidine and S-methylcysteine show a maximum of radioactivity at about 5h (Table 6) , whereas the radioactivities of serine, methionine, 'methylarginine', and the peak containing predominantly dimethyl-lysine, all increase slightly between 5 and 24 h. The maximum amount of alkylation may occur some time after 5h, since there is still some dimethylnitrosamine unchanged at this time (Heath, 1962) . To compare the turover of enzymically incorporated methyl groups with that of the polypeptide chain, rats were injected with a tracer dose of L-[Me-14C]methionine (25,tCi/rat) and histones prepared at 2, 5 or 24h. The radioactivities of serine, methionine and the methylated amino acids increase between 0 and 5h and decrease between 5 and 24h (Table 7 ). Table 7 also shows (final column) that administration of dimethylnitrosamine slows down the decrease in radioactivity between 5 and 24h. Either with or without dimethylnitrosamine treatment, the radioactivities of methylated lysines and of methylated arginine at 5 and 24h are approximately proportional to that of methionine.
To test whether histones were alkylated by carcinogenic nitrosamines other than dimethylnitrosamine, rats were injected with [1_14C]diethylnitrosamine (81mg/kg; specific radioactivity 16.4,uCi/mg) and killed 6h later. A hydrolysate of the liver histones of these rats contained at least three radioactive basic compounds, which eluted from the column later than the methyl-lysines and methylhistidines. No radioactivity was found with a retention volume corresponding to serine, methionine, cystine, the methylated lysines, or the methylhistidines. The total radioactivity of the basic compounds corresponded to 54.6nmol of ethyl group/g of histone. Figs. 3 and 4) . Thus the presence of 3-methylhistidine is also evidence for alkylation of the histones by dimethylnitrosamine.
The interpretation of the 14C-labelling of methyllysine is more complex, since methyl-lysines are normal constituents of rat histones (Murray, 1964) , and the methyl groups can become labelled via the Cl system (Fig. 4) and methionine (Fig. 3) . Three lines of evidence support the view that part of the methyl-lysine in the liver histones of dimethylnitrosamine-treated rats is formed by the action of an alkylating metabolite of the carcinogen. First, the radioactivity of methyl-lysine is higher than that expected from the labelling by C, intermediates; in liver histones from rats given [14C]-formate, methyl-lysine contains 1-3% of the radioactivity of serine, whereas in [14C]dimethylnitrosamine-treated animals methyl-lysine has 15-30% of the radioactivity of serine. More significantly, the methyl-lysine/dimethyl-lysine radioactivity ratio is higher in the dimethylnitrosamine-treated rat than in rats treated with formate or methionine (compare Figs. 2 and 6 with Figs. 3 and 4) .
Secondly, evidence for direct alkylation comes from the experiments with doubly labelled carcinogen. Since these showed that methyl-lysine in the liver histones had a 3H/14C ratio closer to that of the injected dimethylnitrosamine than to that of S-adenosylmethionine, the precursor of enzymically incorporated methyl groups, it becomes clear that most of the [14C,mothyl-lysine is the product of attack by the active metabolite of dimethylnitrosamme.
In the double-labelling experiments, the anomalous isotope ratios of serine and adenosylmethionine can be explained by the isotope effect observed with doubly labelled formate. Serine and adenosylmethionine in the dimethylnitrosamine-treated animals showed a 70% enrichment in tritium compared with the theoretical value for formate; in formate-treated animals, serine was 70% enriched intritium compared with the injected formate. The hydrogen isotope effect in the utilization of intermolecularly double-labelled formate was first described by Rachele, Kuchinskas, Knoll & Eidinoff (1959) , who found that urinary formate and the methyl groups of choline and creatine were enriched in tritium to the extent of 60-70% after injection of triply labelled formate into rats. The present results are in good agreement with theirs. The isotope effect has been ascribed to a preferential utilization of [1H] formate in the rapid oxidation of formate to carbon dioxide, leading to enrichment of the residual formate with tritium (Kuchinskas, Horvath & Rachele, 1959) .
The isotope ratio of methionine in liver histones of dimethylnitrosamine-treated rats is too high to be explained in this way: it is similar to that of the injected compound, and higher than that of Sadenosylmethionine, although both protein methionine and adenosylmethionine derive from the free methionine pool. It is also worth noting that, in the liver and kidney histones of rats treated with [14C]-dimethylnitrosamine, the radioactivity of methionine is about four times as high, relative to serine, as in rats given [14C] formate. This latter observation, taken alone, could be explained by a change in relative pool sizes; but in conjunction with the double-labelling results, it suggests that intact methyl groups from the carcinogen are being transferred to methionine residues in the histones. This would involve formation of an S-methylmethionine sulphonium residue in the protein: such protein- bound sulphonium compounds have been shown to be major forms of binding of azo-dye carcinogens (Scribner, Miller & Miller, 1965) and of acetylaminofluorene (Barry, Malejka-Giganti & Gutmann, 1969) . Under conditions of acid hydrolysis similar to those used in the present study, protein-bound S-methylmethionine is degraded, the major product (91 %) being methionine (Link & Stark, 1968) . Thus, since the two methyl groups of S-methylmethionine are indistinguishable, the hydrolysate would contain methionine some of whose methyl groups were derived directly from the alkylating intermediate. The conclusion that methionine residues in histones are alkylated by dimethylnitrosamine must remain tentative, since no further evidence on this point was obtained. The third line of evidence for the alkylation of lysine residues comes from the variation of radioactivity with time after dosing. Experiments in which [14C]methionine was used to label liver histones showed that the enzymically incorporated methyl groups turn over at approximately the same rate as the polypeptide chain (Table 7 ). In contrast, Table 6 shows that, whereas the radioactivities of serine, dimethyl-lysine and methylarginine rise between 5 and 24h after a dose of
[14C]dimethylnitrosamine because of continued utilization of [14C] formaldehyde, the radioactivities of methyl-lysine, 3-methylhistidine and methylcysteine fall. The decline in activity of methyllysine relative to other histone constituents is not due to a differential effect of the carcinogen on the turnover of the polypeptide chain and the methyl groups; this is shown by the fact that dimethylnitrosamine treatment does not change the approximate proportionality between methyllysine radioactivity and serine and methionine radioactivity in histones pre-labelled with [14C]-methionine (Table 7 , final column). The preferential loss of the alkylated residues in histones could be explained by necrosis since it is likely that the cells whose constituents were most highly alkylated would be most likely to be damaged. The disappearance of alkylated histones follows a similar time-course to that observed with liver and kidney nucleic acids (Craddock & Magee, 1963) , reaching a maximum at 5h after injection and declining between 5h and 24 h.
In the experiments with [14C]dimethylnitrosamine, the presence of radioactivity in the 'methylarginine' residues of liver and kidney histones has been noted. This might suggest that arginine residues are alkylated by dimethylnitrosamine: Friedman, Shull & Farber (1969) have shown that the carcinogen ethionine specifically ethylates arginine residues in rat liver histones. In the doublelabelling experiments, the methylarginine fractions contained insufficient radioactivity for the isotope Bioch. 1971, 124 Vol. 124 737 0 24 ratio to be estimated, so that these experiments gave no information on whether part of the methylarginine was formed from the alkylating intermediate. Such evidence as there is suggests that the major part was not, since (a) unlike methyllysine, methylarginine in histones of [14C]dimethylnitrosamine-treated animals showed no excess of radioactivity over that predicted from the serine radioactivity and the [14C]formate labelling, and (b) unlike methyl-lysine, 3-methylhistidine and methylcysteine, methylarginine does not show a decline in radioactivity between 5 and 24h after a dose of [14C]dimethylnitrosamine (Table 6 ). Thus the principal sites of histone alkylation detected in this study are lysine, histidine, cysteine and possibly methionine residues. Structural modifications such as these could have profound effects on the function of histones, for have concluded from the very close similarity between calf and pea histone F2al (histone IV) that the function of this histone depends on a very specific structure for the whole of the molecule. The alkylation of lysine, histidine, methionine or cysteine residues could have a steric effect on the interaction of histones with DNA or with other regulatory molecules possibly leading to a change in the function of the histones. In addition, alkylation of methionine would increase the net positive charge of the molecule; this would be significant since in histones F2al (histone IV; DeLange, Fambrough, Smith & Bonner, 1969) , F2b (Iwai, Ishikawa & Hayashi, 1970) and F3 (histone III; DeLange, , the methionine residues occur in regions of the molecules containing predominantly neutral and acidic amino acids. Alkylation of cysteine residues would prevent the formation of disulphide bridges, either between two molecules of histone F3, or between histone F3 and non-histone proteins: the significance of this is that the thiol form of histone F3 is predominant in metabolically active chromatin, whereas the disulphide form is predominant in metabolically inert chromatin (Sadgopal & Bonner, 1970a,b; Ord & Stocken, 1966) , and hence alkylation of cystine residues in histones could contribute to an inhibition of gene repression.
The histone preparations used in these experiments were not purified, and therefore it is necessary to consider the possibility that the alkylated products detected were derived from contaminants. However, the similarity of amino acid composition to that of purified rat liver histone preparations shows that major contamination is unlikely. Table  8 shows that total nuclear proteins have similar amounts of alkylation to the histone preparations, after allowing for differences in amino acid composition (Table 1) . This implies that a minor contaminant would need to be exceptionally highly alkylated to explain the amount of alkylation in the histone preparations.
In assessing the possible role of histone alkylation in carcinogenesis by dimethylnitrosamine it is useful to compare the extent of alkylation by dimethylnitrosamine in the two organs studied, and also to compare alkylation by dimethylnitrosamine with that by other alkylating carcinogens (Table 8) .
There is no evidence of a correlation between the extent of alkylation and the ultimate carcinogenic effect. Thus liver histones are more highly alkylated by dimethylnitrosamine than kidney histones; this dose of dimethylnitrosamine causes kidney tumours but no liver tumours in the rat (Magee & Barnes, 1959) , although prolonged feeding of dimethylnitrosamine does cause liver tumours (Magee & Barnes, 1956 ). Methyl methanesulphonate (120mg/kg) leads to higher degrees of alkylation of liver histones than does dimethylnitrosamine (30mg/kg), although methyl methanesulphonate has not been shown to be carcinogenic in rat liver. These observations are very similar to those by on the alkylation of nucleic acids by dimethylnitrosamine and methyl methanesulphonate. Nevertheless, all three compounds used are carcinogenic under appropriate conditions and it is therefore possible that alkylation of histones may be a necessary but not, in itself, sufficient event in carcinogenesis. For instance an effect on the repressor function of histones might be necessary in order for a genetic modification brought about by the carcinogen to be expressed.
